“We are delighted to be awarded the contract to handle BD’s warehousing and distribution in India. According to the India Brand Equity Foundation, the life sciences and healthcare industry in India is growing rapidly, with an expected compound annual growth rate of over 16 percent from now to the year 2022. This makes the healthcare sector a focus area for DHL Supply Chain — especially in India, which has a 2.8 percent share of the global biopharmaceutical market,” said Terry Ryan, CEO, DHL Supply Chain Asia Pacific.
“BD is continuously looking at ways to serve our customers and patients better. This journey with DHL Supply Chain is one such initiative; improving our ability to reach different geographies and in ways that delight our customers, enabling us in advancing the world of health,” said Pavan Mocherla, Managing Director for India & South Asia, BD.
The project is in implementation, with major sites already having gone live, and the rest scheduled for completion by mid of 2019. Among them is a new temperature-controlled site that has been inaugurated in the northern-Indian city of Luhari, Haryana.